Tuesday, June 29, 2021 5:37:50 AM
Creso Pharma Limited (ASX: CPH) (the ‘Company’) requests the voluntary suspension of all quoted securities of the Company, pending an announcement regarding a material sales and revenue update, as announced to ASX on 25 June 2021.
The Company requests that its securities remain in suspension until the release of the aforementioned announcement, which is expected to be lodged on or before Thursday, 1 July 2021.
https://www.cresopharma.com/investor-information
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM